chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mother called stated that child began with fever about 12 midnight Friday night (Feb. 13. She stated child convulsed 3 times and threw up. When asked how high the temp got she stated they could not always get the thermometer in his mouth as his teeth were chattering, but she thought it around 102-103. Mother states he took a 4 hour nap on Saturday and was better on Sunday. She did not take him to the doctor or ER as she stated he convulses from fevers and is made better with tepid baths.
I did not have any symptoms but when I was having my general check up with my cardiologist and I was having a stress test he said that there was an abnormality with my heart and this all happened after my vaccination. I don't know if this has any relation to the vaccine but just for documentation purposes.
After recieveing the vaccine I began to excessively bleed, which is something I have never experienced with an injection. I was very lightheaded and instructed to rest. My arm was very sore at the site of the injection and beyond, it soon became quite difficult to move my arm because of the pain. I iced it and when I woke up the next day, I noticed significant numbness in my left arm. I went to the doctor and a large hematoma was discovered, which took a long time to heal. My left hand and arm are still significantly weaker than my right and I still commonly face numbness in the arm when laying down.
Information has been received from a registered nurse concerning a 16 year old female patient who in August 2009, was vaccinated with the second dose of GARDASIL (lot# not reported) in another health care facility. However, after the second dose was administered, the patient experienced vision problems, difficulty focusing and dizziness. Unspecified medical attention was sought. At the time of this report, all the patient's issues had resolved in 2 weeks. No further information is available.
On or about 12/2/2021 I developed a  nodule in my right hand  and left foot and it has progressed very quickly. On 12/27/2021 went to Black Hills Orthopedic and PA stated I have dupuytrens/ledderhose. None of my family has this disease and believe it could be due to vaccine.  Looking into treatment now. the progression of the lump is rather unsettling. After doing research this could be a disabling event for my hands and feet.
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. There was no medical history or drug reaction/allergies reported. On unknown dates, the patients were vaccinated with doses of improperly stored PROQUAD (Merck) (lot # L005297 with expired date 17-AUG-2016, lot# L009209 with expired date 17-SEP-2016, lot# L009207 with expired date 17-SEP-2016, lot# L023113 with expired date 24-DEC-2016, dose and route were unknown). No concomitant medication was reported. The reporter could not tell how many of each lot number of the vaccine had been administered. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected since the reporter refused to be contacted.
I had chills at 9:30 with fever of 100.4 then at midnight went up to 103 been taking Tylenol and Alieve fever has been going up and down all day today
G45.9 TRANSIENT CEREBRAL ISCHEMIA 3/1/2022 ULCER OF RIGHT ANKLE, UNSPECIFIED DEPTH G45.9 TRANSIENT CEREBRAL ISCHEMIA 3/1/2022 LYMPHADENOPATHY
This spontaneous report as received from an other health professional refers to an approximately 11 year old female patient with migraine and no known allergies. On 07-JUN-2017 the patient was vaccinated with VARIVAX dose 3 for prophylaxis. Concomitant therapies included IMITREX. In 2008 the patient experienced product use issue. On 07-JUN-2017 the patient experienced off label use. In June 2017 the patient experienced antibody test negative. The patient received tretament. However, she did not seek medical attention. The outcome of antibody test negative was reported as recovered/resolved, also reported as "She's fine". The outcome of product use issue and off label use is unknown. The reporter considered product use issue and off label use to be not related to VARIVAX.
an expired dose of GARDASIL 9 was administered today; This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender.  The patient's pertinent medical history, drugs reactions or allergies and concomitant medications were not provided.  On 26-OCT-2022, the patient was vaccinated with an expired dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) 0.5 milliliter, administered as prophylaxis (lot number 1687292 has been verified to be a valid lot number with expiration date on 25-AUG-2022, and upon internal validation established as the same date) (vaccination scheme, frequency, route of administration and anatomical site of injection were not provided) There were no previous temperature excursions. No additional information was provided.
After my vaccine I had no symptoms but on Saturday 04-30-2022, I went to the ER at Medical Center because I started to experience strong chest pain, left side radiating to my axilla then to my upper shoulder and down my left hand. I underwent a cardiogram which was negative this occurred at about 6 hours after my symptoms. I do not know if my symptoms were caused by the vaccine.
Thursday 4/24/08, patient received Zostavax injection.  According to patient, injection soreness and itch at injection site began on 4/25/08.  The itch progressed to other sites and she developed a rash over her body.  On Tuesday 4/29, patient experienced angioedema of her lips (swollen to more than double normal size) and esophageal tightness but no trouble breathing.  Patient took several Benadryl-D to help with the swelling and rash.  It was at this point, 4/29 that the patient returned to the pharmacy to report her symptoms.  The pharmacist on duty advised the patient to contact her physician immediately regarding a possible delayed hypersensitivity reaction.  The pharmacist also advised the patient to continue plain Benadryl (not D) 1-2 every 4-6 hours until recommendation by MD.  Pharmacist emphasized the need to contact MD.  Patient was called by pharmacy 1 week later to follow up.  She reports her MD advised her to continue Benadryl but did not require her to come in for a visit.  Patient reports symptoms went away on their own over the next couple days.  She is currently fine.
Employee received an Intradermal flu shot, she came to me to show me her arm which was swollen and reddened more than normal intradermal reactions. I sent her to the ER for evaluation, diagnosis with local allergic reaction.
*A small rash of around 10 mosquito bite size bumps appeared under left armpit and left torso only.  Shot was given in left arm.  There are no bumps anywhere else on body.    *They do not itch, hurt, or bother me.   *It has been almost 72 hours since shot and bumps still remain.
AFTER SHOT GIVEN TO PT..PT PROCEDED TO  OBSERVATION AREA  AND SAT DOWN . AFTER A FEW MINUTES SHE THEN EXPRESSED SHE FELT LIKE SHE WAS GOING TO PASS OUT. DID NOT PASS OUT. RPH ATTENDED TO HER IMMEDIATELY. SHE SAID SHE FELT FAINT.  I GAVE HER WATER AND TOLD HER TO RELAX. SHE SAID SHE FELT BETTER AFTER A FEW MINUTES
Intermittent Tachycardia; Shortness of Breath; Chest discomfort; Slept for 12 hours straight/Unable to get out of bed; Became very fatigued; Had headache; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Intermittent Tachycardia), DYSPNOEA (Shortness of Breath), CHEST DISCOMFORT (Chest discomfort), FEELING ABNORMAL (Slept for 12 hours straight/Unable to get out of bed) and FATIGUE (Became very fatigued) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to antibiotic (Amoxicillin) and Exercise induced asthma since February 2000. Concomitant products included CURCUMA LONGA (TURMERIC [CURCUMA LONGA]) and PROBIOTICS NOS for an unknown indication.   On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced TACHYCARDIA (Intermittent Tachycardia), DYSPNOEA (Shortness of Breath), CHEST DISCOMFORT (Chest discomfort), FEELING ABNORMAL (Slept for 12 hours straight/Unable to get out of bed), FATIGUE (Became very fatigued) and HEADACHE (Had headache). At the time of the report, TACHYCARDIA (Intermittent Tachycardia), DYSPNOEA (Shortness of Breath) and FEELING ABNORMAL (Slept for 12 hours straight/Unable to get out of bed) had resolved and CHEST DISCOMFORT (Chest discomfort), FATIGUE (Became very fatigued) and HEADACHE (Had headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 145 (High) Heart rate elevated to 145 - 150 (When attempting to go upstairs).     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Lab investigations included: Troponin, Sedimentation rate, CBC, CMP and also Echocardiogram, Holter monitor- Where all the results were in their normal ranges  Other concomitant medications include: Mushroom immune booster which are taken orally  Treatment information was not reported   This case was linked to MOD-2021-010602 (Patient Link).
Injection was high up on left arm - pain at and around the injection site was fairly severe for several days. Now, one month after the injection, mild pain persists and movement of the arm/shoulder is impaired.
"COVID Arm" Bright red itchy rash at injection site 8 days later Insomnia 8 nights later
Fever, headache, dizziness and nausea. After 24 hours of fever gave Tylenol.
itchy on his legs; irritating red bumps on arms, irritating red bumps on hands; flakey skin; blotchy skin; discolored skin; severely scarred; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (itchy on his legs), RASH ERYTHEMATOUS (irritating red bumps on arms, irritating red bumps on hands), SKIN EXFOLIATION (flakey skin), RASH MACULAR (blotchy skin) and SKIN DISCOLORATION (discolored skin) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included CHLORTHALIDONE and AMLODIPINE for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PRURITUS (itchy on his legs), RASH ERYTHEMATOUS (irritating red bumps on arms, irritating red bumps on hands), SKIN EXFOLIATION (flakey skin), RASH MACULAR (blotchy skin), SKIN DISCOLORATION (discolored skin) and SCAR (severely scarred). The patient was treated with CLOBETASOL at a dose of 50 ml and TRIAMCINOLONE at a dose of 454 gram. At the time of the report, PRURITUS (itchy on his legs), RASH ERYTHEMATOUS (irritating red bumps on arms, irritating red bumps on hands), SKIN EXFOLIATION (flakey skin), RASH MACULAR (blotchy skin), SKIN DISCOLORATION (discolored skin) and SCAR (severely scarred) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient reported 95% of the symptoms were resolved.       Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow-up information received on 23-JUN-2021 contains No significant information On 10-Jul-2021: Follow-up information received on 10-JUL-2021 contains Non-significant follow up.
Some left shoulder socket pain; Felt sluggish; Woke up with headache; Felt drained; Hip socket pain; Chills; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ZW0177), via an unspecified route of administration in the left arm on 15May2021 at 16:30 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN) 10 mg and famotidine (MANUFACTURER UNKNOWN) 20 mg; both from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736), via an unspecified route of administration in the left arm on 24Apr2021 at 15:00 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16May2021 at 07:00, the patient woke up with headache. As day went on felt sluggish, felt drained, some hip socket pain. Sunday (16May2021) night at bed time had chills.  On 17May2021, Monday the patient started feeling normal. Some left shoulder socket pain which was subsided. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headache, felt sluggish, felt drained, some hip socket pain, chills, and some left shoulder socket pains were resolved on an unknown date in May2021.   No follow-up attempts are possible. No further information is expected.
When I received the vaccine I felt very tired but after a few days I had facial paralysis, the next day I went to the emergency since I felt so bad.
prostate cancer; Had some pain 1st and 2nd at injection site; some joint pain next 3 to 9 days; The initial case was missing the following minimum criteria: no adverse event. Upon receipt of follow-up information on 19Apr2021, this case now contains all required information to be considered valid.  This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported that a male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on 14Jan2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Vaccination facility type was hospital. Patient received the first dose of the vaccine and is due to receive the second dose on 04Feb2021. On 03Feb2021, he is due to receive a steroid injection in his back and was wondering if the two are compatible. He will have his injection shot at his lower back the day before his 2nd dose vaccine. It was further reported that on 14Jan2021, the patient received his first covid vaccine and had some pain 1st and 2nd (day) at injection site (14Jan2021) and some joint pain next 3 to 9 days (Jan2021), went into hospital for prostate cancer on 02Feb2021. The patient experienced prostate cancer on an unspecified date. The patient was hospitalized for prostate cancer from 02Feb2021 to an unknown date. They would not give him 2nd vaccine at hospital. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sore arm, chills/aches, lack of energy (very tired all the time), no treatment yet
sensitivity to light; This spontaneous case was reported by a consumer and describes the occurrence of PHOTOPHOBIA (sensitivity to light) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031b21a) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Codeine), Hypertension since 2005, Vitreous floaters since 1990 and Migraine (Ocular,occurs less than twice a year) since 2018. Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) from 2005 to an unknown date for Hypertension, MULTIVITAMIN FOR WOMEN from 1988 to an unknown date for an unknown indication.    On 06-Apr-2021 at 9:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021 at 9:30 AM, the patient experienced PHOTOPHOBIA (sensitivity to light). On 07-Apr-2021, PHOTOPHOBIA (sensitivity to light) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not provided.  The patient had similar event in the past during eye dilation by ophthalmologist.   This case was linked to MOD-2021-221194 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow-up received on 14-JUN-2021. Updated patient demographics, medical history, concomitant medication and event outcome changed from not recovered to recovered with stop date.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported event of Photophobia, a causal relationship cannot be excluded.
Heart started to race, face flushed, sweaty forehead and palms, felt hot.   lasted approx 1 min, and slowly went away after 5min or so....  I did not notify anyone.
shaking chills; shaking chills; This case was reported by a physician via call center representative and described the occurrence of tremor in a 68-year-old female patient who received Herpes zoster (Shingrix) (batch number 98C4B, expiry date 20th November 2022) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 27th October 2021, the patient received the 2nd dose of Shingrix. On 27th October 2021, less than a day after receiving Shingrix, the patient experienced tremor and chills. On an unknown date, the outcome of the tremor and chills were not recovered/not resolved.   It was unknown if the reporter considered the tremor and chills to be related to Shingrix.  Additional information was provided as follows: The case was reported by patient's husband. In mid-August 2021, the patient received the 1st dose of Shingrix. The patient received the vaccine and developed shaking chills and till the time of reporting, it was ongoing. The reporter consented to follow up.
Increase temperature 101.6 and 103.6, temperature spikes at night, eyes red.  Advised parent to take child to emergency room.
Got extreme flu like symptoms in a couple hours after shot given. Now 5 days later extremely ill.
Hospitalization for SIRS due to COVID-19 on dates  10/23/22- 10/30/22. Treated with dexamethasone, Remdesivir, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Information has been received from a healthcare worker referring to multiple unspecified patients of unknown age and gender. The patients' concurrent conditions, concomitant medication and medical history were not provided. On unknown dates the patients were vaccinated with improperly stored VAQTA (Lot# L017757, exp. 08-APR-2018; Lot# K007791, exp. 22-AUG-2016) (dose, route and dose number were unspecified). No adverse effects were reported. This is one of several reports received from the same source. Additional information is not expected because there was no consent to contact physician.
Sore Arm with moderate pain, redness and swelling. (day 1 and 2) Fever, nausea, body aches, headache, tiredness (cont. day 2)
Breakthrough case admission after 4 vaccines Moderna 2/19/21 Lot# 015M20A;  Moderna 4/1/21 Lot# 026B21A;  Moderna 12/4/21 Lot# 034F21A;  Moderna 8/1/22 Lot# 011B22A
Teeth shaking chills, mild nausea and headache occurred at 2 AM. Significant weakness for 24 hours. I weigh 120 lbs. My friend who had to go to ER due to fainting, weighs less. A patient that I administered a Shingrix fainted the next day. All of us are small women. Is this vaccine something that should be dose aligned with weight?
After the shot I had nausea and was dizzy. As time went on my lymph nodes under my arm and on my neck became extremely swollen and still have not totally gone down. I also had fatigue/tiredness, and a bad headache.
pt states that inj site from pneumonia shot from 8SEP97 was swollen & red;no real pain & would call if got worse or didn't go away;pt states better 22SEP97;
hives all over the body; I had ithcy hands, palms, and itchniess all over body.; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives all over the body) and PRURITUS (I had ithcy hands, palms, and itchniess all over body.) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 022MZ0A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy.   On 17-Feb-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021 at 11:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced URTICARIA (hives all over the body) and PRURITUS (I had ithcy hands, palms, and itchniess all over body.). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEK) (oral) ongoing from 15-Apr-2021 for Pruritus and Hives, at a dose of 10 mg once a day and PREDNISONE (oral) from 09-Apr-2021 to 12-Apr-2021 for Pruritus and Hives, at a dose of UNK, bid. At the time of the report, URTICARIA (hives all over the body) and PRURITUS (I had ithcy hands, palms, and itchniess all over body.) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Apr-2021, Allergy test: negative (Negative) My food allergy testing came back negative.         Concomitant product use was not provided by the reporter.  The patient reported that he attempted to stop taking the Zyrtek, but when he does, the itchiness and hives returns.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Initial additional included significant update: new event, allergy history, lab test
Had initial local site tenderness for first 2 days, then resolved. On 4/8/21 noticed a warm, itching ,red and raised area 1-2 inches around. States that the itching and redness comes and goes. She did contact her pcp who advised her to apply a cool compress.
DIZZINESS,  NAUSEA  FEELING FINE AFTER 5 MINUTES
This spontaneous report as received from a nurse practitioner via a company representative refers to an unspecified number of patients of unknown age and gender. The patients' medical history was not reported. On an unknown date, the patients were vaccinated with doses of ZOSTAVAX (lot #, dose, route and site of administration were not reported) for prophylaxis. Concomitant medications were unknown. On unknown dates, the patients developed shingles. The outcome of event was unknown. The relatedness between the event and ZOSTAVAX was not reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1704USA003801: